Spark Biomedical Introduces Sparrow Link: A Revolutionary Research Platform for Non-Invasive Neurostimulation
September 05, 2024 09:00 ET
|
Spark Biomedical
Dallas, TX, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a global pioneer in wearable neurostimulation solutions, proudly announces the launch of Sparrow Link, a revolutionary research...
Spark Biomedical Has Been Issued New CMS Codes for Transcutaneous Auricular Neurostimulation (tAN®) Therapy via Sparrow Ascent
August 28, 2024 09:38 ET
|
Spark Biomedical
Dallas, TX, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Dallas, TX [August 2024] – Spark Biomedical, Inc., a leader in non-invasive neurostimulation technology, has been issued two unique Healthcare Common...
Behind the Scenes of Medical Innovation: Spark Biomedical launches new web series ‘Spark a Conversation’
July 01, 2024 09:48 ET
|
Spark Biomedical
Dallas, TX, July 01, 2024 (GLOBE NEWSWIRE) -- For as long as there has been opioid use disorder, there have only been two solutions: cold turkey or more drugs. The founders of Spark Biomedical...
EY Announces Spark Biomedical CEO Daniel Powell as an Entrepreneur Of The Year® 2024 Southwest Award Finalist
April 19, 2024 15:01 ET
|
Spark Biomedical
Dallas, TX, April 19, 2024 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) today announced that Daniel Powell, CEO and Founder of Spark Biomedical was named an Entrepreneur Of The Year® 2024...
Spark Biomedical Awarded $1.15M Department of Defense Phase II STTR Grant in Partnership with Battelle Memorial Institute
August 29, 2023 14:52 ET
|
Spark Biomedical
DALLAS, Texas, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Aug. 29, 2023 — Spark Biomedical, Inc., a Dallas-based pioneer in wearable neurostimulation technology, was awarded a $1.15M Phase II grant to...
Spark Biomedical Launches Telehealth Services for Sparrow Ascent, Improving Patient Access to Opioid Withdrawal Treatment
August 08, 2023 12:05 ET
|
Spark Biomedical
DALLAS, TX, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Spark Biomedical Launches Telehealth Services for Sparrow Ascent, Improving Patient Access to Opioid Withdrawal Treatment August 8, 2023, Dallas, TX...
Spark Biomedical’s second-generation device, Sparrow® Ascent, Receives FDA Clearance for Opioid Withdrawal Relief in Adults
July 11, 2023 14:54 ET
|
Spark Biomedical
DALLAS, TX, July 11, 2023 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc., a leading innovator in wearable neurostimulation development, is proud to announce that its next-generation, groundbreaking...
Spark Biomedical’s second-generation device, Sparrow® Ascent, Receives FDA Clearance for Opioid Withdrawal Relief in Adults
July 11, 2023 14:38 ET
|
Spark Biomedical
DALLAS, TX, July 11, 2023 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc., a leading innovator in wearable neurostimulation development, is proud to announce that its next-generation, groundbreaking...
Spark Biomedical’s second-generation device, Sparrow® Ascent, Receives FDA Clearance for Opioid Withdrawal Relief in Adults
July 11, 2023 14:31 ET
|
Spark Biomedical
DALLAS, TX, July 11, 2023 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc., a leading innovator in wearable neurostimulation development, is proud to announce that its next-generation, groundbreaking...
Five Liters sets clinical sights on novel bioelectric treatment for von Willebrand Disease
July 06, 2023 14:37 ET
|
Spark Biomedical
DALLAS, TX and MANHASSET, NY, July 06, 2023 (GLOBE NEWSWIRE) -- Five Liters, a Dallas-based wearable neuromodulation company, is embarking on a series of groundbreaking first-in-human studies to...